N2B-PATCH

The N2B-patch project is an EU-funded project that started in January 2017. N2B-patch stands for Nose-to-Brain-patch. We aim to develop an innovative technology for multiple sclerosis (MS) treatment by developing a ‘nose to brain' delivery system which will avoid the need for injections and oral medicine. The long-term objective is to improve treatment of MS patients... We aim to develop an innovative N2B drug delivery technology for the treatment of MS based on the synthesis of a biomaterial-based innovative galenic formulation, a novel class of hydrogel matrix-patch and a medical applicator device system. The N2B route of administration provides a minimally invasive method of bypassing the blood-brain-barrier (BBB). Moreover, the innovative multifunctional galenic formulation of N2B-patch aims to shield sensitive drugs and maintain the drug's bioactivity... The multidisciplinary consortium of N2B-patch brings together Universities, Research institutes, SMEs and Industry with..

Primary location: Stuttgart Germany